LONDON--(BUSINESS WIRE)--The pharmaceutical manufacturing industry is considered one of the top 10 industries with the highest barriers to entry. With various trends and growth drivers such as higher life expectancy, rising awareness about health and wellness, and high prevalence of chronic diseases are substantially propelling growth in the industry. However, challenges such as high R&D costs, challenging regulatory approval processes, and intellectual property obstacles are making it increasingly difficult for new companies to enter this competitive market. Infiniti’s market entry analysis enables pharmaceutical manufacturing companies to identify, evaluate, and efficiently maneuver these barriers to entry. It also equips them to establish their brand and gain significant market share in a highly challenging market.
Request a free proposal to gain comprehensive insights into overcoming the barriers to entry in the pharmaceutical manufacturing industry, and champion the industry.
“Although awareness about health and wellness is growing, the prevalence of terminal and chronic diseases has grown substantially in recent years, and the need for pharmaceutical drug discovery and development has increased,” says a pharmaceutical manufacturing industry expert at Infiniti Research.
The COVID-19 pandemic has taken a significant toll on the pharmaceutical manufacturing industry in recent months. As the industry recovers, pipeline players are attempting to establish their brand in this highly competitive industry. While changing market dynamics and new trends, are serving as highly impactful market growth drivers and the industry is on the path to recovery. The biggest challenge, however, continues to be the various barriers to entry in the pharmaceutical manufacturing industry. To assist new companies in their attempts, Infiniti’s experts analyzed the market and identified four significant barriers to entry. In their recent article, the experts discuss the major barriers to entry and explain how market entry analysis can help companies efficiently establish themselves in the pharmaceutical manufacturing industry.
Speak with our industry experts and take a crucial step towards growth and overcoming the challenging barriers to entry in the pharmaceutical manufacturing industry.
Infiniti’s experts identified the following four significant barriers to entry in the pharmaceutical manufacturing industry:
- Economies of Scale: Having a well-established distribution network, and appropriate infrastructure is crucial and challenging for newer companies, giving established companies a substantial advantage
- Regulations and Approval: Obtaining all prerequisite regulatory approvals before marketing or distributing a new drug is a long-drawn and extremely expensive, particularly for new companies
- Investment Capital: Starting a pharmaceutical manufacturing company requires large investments in infrastructure, and R&D, with the possibility of not earning revenue for over a decade.
- Intellectual Property and Patents: Patents serve as a legal and strategic safeguard for established companies and help them stop new companies from entering the market without a completely new pharmaceutical drug.
Request more information to learn about the benefits of market entry analysis for pharmaceutical companies attempting to compete in the challenging pharmaceutical manufacturing industry.
About Infiniti Research
Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us
